張浩鈞醫生 - 病理學
病理學專科醫生
重點資料
- 醫務委員會註冊已驗證
- 病理學專科醫生香港大學內外全科醫學士 · 香港病理學專科學院院士 · 2013 年醫科畢業
- 保險計劃資料整理中｜查看詳情
關於醫生
張浩鈞醫生是香港註冊的病理學專科醫生。
學歷
保險計劃
常見問題
張浩鈞醫生好嗎？
張浩鈞醫生是香港註冊的病理學專科醫生。資歷及註冊資料來自香港醫務委員會。ok.med 不評分，也不排名。
張浩鈞醫生是做什麼的？
張浩鈞醫生是病理學醫生。
研究及論文
共 26 篇，顯示最近 12 篇
按論文主題篩選
主題由同一批 PubMed 論文的醫學分類整理，不代表醫生提供相關診治服務。
- HES1 inhibition overcomes CDK4/6 inhibitor resistance by targeting cancer stemness in lung adenocarcinoma.Journal of experimental & clinical cancer research : CR · 2026
- Hepatic TM6SF2 activates antitumour immunity to suppress metabolic dysfunction-associated steatotic liver disease-related hepatocellular carcinoma and boosts immunotherapy.Gut · 2025
- Targeting of the m<sup>6</sup>A eraser ALKBH5 suppresses stemness and chemoresistance of colorectal cancer.Nature communications · 2025
- Peptostreptococcus anaerobius mediates anti-PD1 therapy resistance and exacerbates colorectal cancer via myeloid-derived suppressor cells in mice.Nature microbiology · 2024
- SMARCA4 deficiency and mutations are frequent in large cell lung carcinoma and are prognostically significant.Pathology · 2024
- FOXP4 Is a Direct YAP1 Target That Promotes Gastric Cancer Stemness and Drives Metastasis.Cancer research · 2024
- METTL3 drives NAFLD-related hepatocellular carcinoma and is a therapeutic target for boosting immunotherapy.Cell reports. Medicine · 2023
- Out of the cycle: Impact of cell cycle aberrations on cancer metabolism and metastasis.International journal of cancer · 2023
- Targeting YAP1/TAZ in nonsmall-cell lung carcinoma: From molecular mechanisms to precision medicine.International journal of cancer · 2023
- MLK4 promotes glucose metabolism in lung adenocarcinoma through CREB-mediated activation of phosphoenolpyruvate carboxykinase and is regulated by KLF5.Oncogenesis · 2023
- Interpretation of Lung Cancer Plasma EGFR Mutation Tests in the Clinical Setting.American journal of clinical pathology · 2023
- Cancer-associated fibroblasts in nonsmall cell lung cancer: From molecular mechanisms to clinical implications.International journal of cancer · 2022
論文資料來自 PubMed／Europe PMC，按姓名及機構自動配對；每項均可按連結核對。
僅供參考，不構成醫療建議。 閱讀完整免責聲明